Brief: DRI Healthcare Trust Announces Acquisition Of Royalty Interest In Pegcetacoplan

DRI Healthcare Trust

21/07/2022 12:58

July 21 (Reuters) - Dri Healthcare Trust  DHT_u.TO :
    * DRI HEALTHCARE TRUST ANNOUNCES ACQUISITION OF A ROYALTY
INTEREST
IN THE WORLDWIDE SALES OF PEGCETACOPLAN INCLUDING EMPAVELI®
/ASPAVELI® FOR THE TREATMENT OF PAROXYSMAL NOCTURNAL
HEMOGLOBINURIA
    * DRI HEALTHCARE TRUST - UNIT OF DRI HAS ACQUIRED A ROYALTY
INTEREST IN PEGCETACOPLAN FOR AN UPFRONT PURCHASE PRICE OF
US$24.5 MILLION

Source text for Eikon:  ID:nCNWLV48Da 
Further company coverage:  DHT_u.TO 

 ((Reuters.Briefs@thomsonreuters.com;))